Impact Biomedical Inc. Files Form F-4 for Proposed Merger with Zoar

What Happened
Impact Biomedical Inc. (IBO) announced on September 16, 2026 that it filed a Form F-4 registration statement in connection with its proposed merger with Zoar Limited (f/k/a Dr Ashleys Limited). The company furnished a press release about the filing on an 8-K dated September 17, 2026.

Key Details

• Press release dated September 16, 2026; Form 8-K filed September 17, 2026 (Item 7.01, Regulation FD Disclosure).
• The Form F-4 was filed in connection with the proposed merger between Impact Biomedical and Zoar Limited (formerly Dr Ashleys Limited).
• The 8-K includes Exhibit 99.1 (the press release) and an Inline XBRL cover page (Exhibit 104).

Why It Matters
Filing a Form F-4 is a formal step toward registering any securities that may be issued in the proposed merger and signals that the transaction process is advancing. For investors, this filing is a cue to watch for follow-up disclosures (final registration statements, proxy materials, shareholder votes or regulatory approvals) that could affect timing, ownership and the company’s capital structure if the merger proceeds.